Previous studies have reported certain components of the ghrelin system in GEP-NETs22,42–44; however, to our knowledge, this is the first study that comprehensively characterizes these components in tumor samples compared to their corresponding adjacent non-tumor regions, as well as with normal tissue samples. This evidence concerns the gene GHRL and neoplasm.